U.S. Stock News

Curious if Iovance Biotherapeutics might be deeply undervalued, or if there's a catch behind the low share price? You're not alone. We're diving straight into what might be driving investor interest right now. The stock has had a rough ride, losing 9.5% in the past week and a staggering 85.1% over the last year, so there’s no denying that volatility and risk perception are front of mind for investors. Recently, clinical trial updates related to Iovance’s cancer immunotherapy platform and...

Kyndryl Holdings (KD) has turned profitable for the first time, reporting impressive annual earnings growth of 50.2% over the past five years. Looking ahead, earnings are projected to grow at 42.6% per year, significantly above the US market’s 15.8% average, while revenue is expected to rise at a more modest 3.5% per year. The company’s net profit margin has improved, making profitability the highlight of this latest release. See our full analysis for Kyndryl Holdings. Now, let’s see how...

MNTN (MNTN) remains in the red, with net losses having deepened at a pace of 14.8% per year over the last five years and no sign yet of a positive net profit margin. That said, there is a bold turnaround forecast: earnings are projected to grow at a steep 90.92% annually, with a shift into profitability expected within three years. With revenue growth expectations of 18% per year outpacing the wider US market, the latest results put all eyes on whether strong forward momentum will finally...

Zimmer Biomet Holdings (ZBH) posted a net profit margin of 10.5%, down from 13.3% a year ago, marking a drop in profitability as the company absorbed a $304.6 million one-off loss over the last twelve months. While the average annual earnings growth stood at a solid 26.4% over the past five years, recent performance took a hit with negative earnings growth this year, making direct comparisons to historical trends less meaningful. Looking forward, earnings are forecast to increase by 14.2% per...

OppFi (OPFI) just raised its revenue expectations for 2025 and completed a notable share repurchase. These are two clear signals that management is confident about the company’s direction and prospects next year. See our latest analysis for OppFi. After the upbeat revenue outlook and completion of its buyback, OppFi’s positive momentum stands out. The 1-year total shareholder return sits at 89.5%, and its 3-year total return is an impressive 454%. These strong numbers have caught investor...

Curious if PACCAR stock is a good deal right now? Let’s break down whether there’s value hidden beneath the hood. PACCAR’s share price has moved up 2.6% in the last week and 2.3% over the past month, even though it remains down 2.6% year-to-date and 9.6% over the past year. Long-term holders have still seen strong gains of over 100% in five years. Recent news around PACCAR includes supply chain updates and continued investments in electric vehicle development, both drawing attention from...

Ever wondered if Entegris is a hidden gem or if its recent price can be justified? You are not alone. Let’s explore whether it is truly undervalued right now. The stock has been on a bit of a rollercoaster, dropping 6.4% over the last week and losing 11.7% in the past month. This has led to a year-to-date decline of 9.0% and a 15.4% dip over the last year. However, it still boasts a three-year return of 38.2%. Recent news has put Entegris in the spotlight, with industry-wide concerns about...

Ichor Holdings (ICHR) is making headlines after Philip Barros stepped in as CEO, following Jeffrey Andreson’s resignation. This executive transition comes at a time when the company delivered mixed third-quarter results, sparking debate among investors about its next strategic moves. See our latest analysis for Ichor Holdings. Following the CEO transition and mixed earnings, Ichor Holdings’ share price has been on a rollercoaster, surging over 6% in a day after earnings but still lagging...

LTC Properties (LTC) reported net profit margins of 38.7% for the recent period, down from 47.6% a year ago, reflecting a notable decline in profitability. Over the past five years, the company’s earnings have grown 5.9% annually and are projected to increase by 6.47% per year going forward, which is well below the broader US market’s 16% forecasted annual growth. Investors may note that while LTC’s profit outlook trails the market, revenue is expected to climb 32.8% per year, which is...

Pulse Biosciences reported third quarter results showing a net loss of US$19.39 million, widening from US$12.68 million a year earlier, and a nine-month net loss of US$55.35 million compared to US$34.2 million previously. Investors may note this increased loss comes soon after the company began patient enrollment in its NANOCLAMP AF Study, reflecting continued investment in its nonthermal cardiac ablation technology. We'll explore how the combination of growing losses and continued clinical...

Wondering if American Financial Group still offers value at its current price? You are not alone. It is a good time to take a closer look at what the numbers say. The stock has seen some swings lately, climbing 4.1% over the last week but sliding 8.5% in the past month. This might spark questions about growth potential or changes in risk perception. Recent headlines about the insurance industry’s broader outlook and American Financial Group’s expansion into new specialty markets have added...

Live Nation Entertainment (LYV) reported net profit margins of 2.3%, up from last year’s 1.1%, with EPS growth of 107.7% over the past year. That figure easily exceeds the company’s 5-year average annual earnings growth rate of 79.8%. Forecasts call for another 41.6% EPS growth per year going forward, ahead of the US market’s 16%. The company’s profitability streak and rising margins stand out, but a notable non-recurring loss of $412.7 million in the last twelve months adds complexity to the...

Wondering if Freshworks is actually a bargain or just another hype stock? Let’s cut through the noise and get straight to the real drivers of value. The stock has edged up 1% over the past week, but despite a bit of positive momentum, it’s still down about 30% year-to-date and 15.5% over the last year, so the market’s sentiment has definitely shifted. Big moves like these often track with fresh headlines. Talk around Freshworks lately has focused on its expansion into new markets and...

Ever wondered if Valley National Bancorp is a hidden gem or just fairly priced right now? Let's dive into what the numbers are telling us about its true value. The stock has quietly climbed 22.4% year-to-date, with a 0.2% gain over the past month. This suggests shifting investor sentiment or growing optimism in the market. Notably, Valley National Bancorp's recent positive momentum has followed sector-wide discussions on regional bank stability and a renewed focus on loan growth. Increased...

Wondering whether IDEXX Laboratories is a bargain right now? Let's break down what today's price might mean for those looking for value or opportunity. Shares have soared by 14.7% in the past month and capped off an impressive 76.2% surge year-to-date, making it hard to ignore the stock's momentum and the shifting sentiment among investors. Much of the recent excitement can be traced to market buzz around continued strength in the animal diagnostics sector along with growing confidence in...

MasterBrand (MBC) reported net profit margins of 3.4%, down from 6.7% the previous year, as a one-off loss of $46.3 million weighed on results. Over the past five years, earnings have declined by 7.4% annually, with another drop recorded in the last twelve months. Investors are likely weighing the compressed recent margins and negative earnings growth against a share price of $10.81, which sits well below the estimated fair value of $22.87. See our full analysis for MasterBrand. Next, we will...

Lumentum Holdings (LITE) turned the corner this quarter, swinging to positive earnings after several years of declining profitability. Prior EPS dropped by 67.7% per year over the past five years. Analysts now expect earnings to accelerate 28.6% per year and revenue to climb 21.1% per year, both running well ahead of the broader US market. With high-quality earnings emerging, investors are weighing the strong projected growth against a premium valuation and ongoing concerns about Lumentum's...

Wondering if Core Natural Resources could be a hidden gem or just another overhyped stock? You are not alone in trying to figure out if its current price really matches its underlying value. The stock has seen dramatic ups and downs, including a recent decline of 12.2% over the past month and a year-to-date dip of 28.1%. However, the five-year return of 1698.3% is notable. Recent headlines have shed light on regulatory changes and shifting energy market dynamics, which have driven much of...

Curious if IREN stock is the real deal or just another name catching headlines? Here is what investors should know before considering an investment. IREN has seen its share price increase by 26.5% in the past week and 630.5% year-to-date, indicating strong momentum and changing viewpoints on risk and opportunity. Some of this significant growth is linked to positive developments in the cryptocurrency and tech sectors, with IREN often noted in industry coverage as benefiting from rising...

Fiverr International (FVRR) delivered a 54.3% jump in earnings over the past year, outpacing its 5-year annual average growth of 43.4%. Its net profit margin came in at 4.3%, up from 3.2% a year ago, signaling profitability continues to improve. With analyst forecasts predicting earnings growth of nearly 39.8% per year for the next three years, investors are weighing rapid profit expansion and margin gains against a slower 7% revenue growth rate and a recent one-off loss of $3.1 million. See...

Zeta Global Holdings (ZETA) is forecasting revenue growth at an annual rate of 15.5%, outpacing the broader US market's 10.4% forecast. Despite remaining unprofitable and confirming ongoing negative margins, the company has trimmed its losses by 13% annually over the past five years, giving investors some optimism as shares hold steady near $19.94. See our full analysis for Zeta Global Holdings. Next, we will compare these headline statistics with the most widely discussed narratives about...

Clover Health Investments (CLOV) is currently unprofitable, but the company has managed to cut its losses by 25.5% per year over the past five years. Revenue is forecast to grow at 14.9% per year, outpacing the broader US market’s 10.4% growth rate. Meanwhile, earnings are expected to surge at an impressive 77.48% per year, with profitability anticipated within three years. While the share price has experienced volatility in recent months, investors are weighing the mix of swift growth and...

Ashland (ASH) remains unprofitable, but over the last five years it has managed to cut its losses at an annual rate of 4.8%. Revenue is forecast to grow at 3.3% per year, trailing the broader US market’s estimated 10.5% growth. With the stock trading at $50.74, below at least one fair value estimate of $93.63, investors are focusing on valuation and the company’s efforts to narrow losses amid a slower top-line outlook and potential risks to its dividend profile. See our full analysis for...

Axalta Coating Systems recently reported third quarter 2025 results, delivering net income of US$110 million on sales of US$1.29 billion, both reflecting year-over-year changes, while also completing a significant share buyback program and issuing updated financial guidance for the year. The combined updates signal enhanced profitability and capital returns, with Axalta now forecasting full-year net sales to exceed US$5.1 billion and demonstrating disciplined use of capital through ongoing...